Futures
Access hundreds of perpetual contracts
TradFi
Gold
One platform for global traditional assets
Options
Hot
Trade European-style vanilla options
Unified Account
Maximize your capital efficiency
Demo Trading
Introduction to Futures Trading
Learn the basics of futures trading
Futures Events
Join events to earn rewards
Demo Trading
Use virtual funds to practice risk-free trading
Launch
CandyDrop
Collect candies to earn airdrops
Launchpool
Quick staking, earn potential new tokens
HODLer Airdrop
Hold GT and get massive airdrops for free
Pre-IPOs
Unlock full access to global stock IPOs
Alpha Points
Trade on-chain assets and earn airdrops
Futures Points
Earn futures points and claim airdrop rewards
Promotions
AI
Gate AI
Your all-in-one conversational AI partner
Gate AI Bot
Use Gate AI directly in your social App
GateClaw
Gate Blue Lobster, ready to go
Gate for AI Agent
AI infrastructure, Gate MCP, Skills, and CLI
Gate Skills Hub
10K+ Skills
From office tasks to trading, the all-in-one skill hub makes AI even more useful.
GateRouter
Smartly choose from 40+ AI models, with 0% extra fees
Just been scrolling through some wild stock performance data and honestly, some of the moves in the market over the past couple years have been absolutely insane. The S&P 500 is up around 60% in that stretch, which is already crushing its usual 10% annual average, but there are some individual names that have gone completely parabolic.
I stumbled across three that really stand out as top performers, and they're pretty interesting case studies for different reasons. Summit Therapeutics hit like 1,600% gains after their cancer drug ivonescimab showed better results than Merck's Keytruda in trials. That's the kind of move that gets everyone's attention, right? But here's the thing - the company has zero recurring revenue right now, which is a massive risk. The trial was in China too, so there's real uncertainty whether US regulators will even approve it. Feels like a wait-and-see situation to me.
Then there's Carvana, up around 1,330%. The used-car dealer's been on fire as interest rates stabilize and people get more optimistic about auto demand. Their financials actually improved too, which is why investors got excited. But margins are razor-thin, under 20%, and they posted a $72 million operating loss last year. Remember when this stock dropped 98% in 2022? That's the kind of volatility that keeps me up at night. You need consistency before going all-in on something like this.
Nvidia's the one that doesn't surprise anyone. Up 906%, and honestly it could've been higher given the AI boom. CEO Jensen Huang literally said demand for their Blackwell chips is insane - customers are waiting over a year just to get them. In their July quarter, sales jumped 122% year-over-year to $30 billion. That's the kind of growth story that keeps attracting capital.
What's interesting is looking at these three as part of a broader group of top 50 small cap stocks and growth plays that have really moved. Some of them have legitimate business fundamentals improving, while others are riding pure narrative. Summit and Carvana feel riskier to me - they've had massive runs and the downside could be brutal if sentiment shifts. Nvidia's valuation is already huge at nearly $3.5 trillion, so the returns might be more modest going forward, but the business momentum is undeniable.
The real question is whether you're buying these for the next leg up or if you're already late to the party. That depends a lot on your risk tolerance and how much you believe in each company's long-term story.